These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6463864)

  • 41. Partial purification of C-C36 tumor rejection antigen molecules commonly expressed on syngeneic murine colon tumors, C-C36 and C-C26.
    Sato N; Sato T; Takahashi S; Fujimoto N; Koshiba H; Ishii Y; Kikuchi K
    Jpn J Cancer Res; 1986 May; 77(5):473-9. PubMed ID: 3089978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of laparoscopic versus conventional technique in colonic and liver resection in a tumor-bearing small animal model.
    Kuntz C; Kienle P; Schmeding M; Benner A; Autschbach F; Schwalbach P
    Surg Endosc; 2002 Aug; 16(8):1175-81. PubMed ID: 12189479
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual-specific T cells combine proliferation and antitumor activity.
    Kershaw MH; Westwood JA; Hwu P
    Nat Biotechnol; 2002 Dec; 20(12):1221-7. PubMed ID: 12415288
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of blood transfusions on immune function. Part VI. Effect on immunologic response to tumor.
    Waymack JP; Fernandes G; Yurt RW; Venkatraman JT; Burleson DG; Guzman RF; Mason AD; Pruitt BA
    Surgery; 1990 Aug; 108(2):172-7; discussion 177-8. PubMed ID: 2382219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.
    Sato N; Yagihashi A; Okubo M; Torigoe T; Takahashi S; Sato T; Kikuchi K
    Cancer Res; 1987 Jun; 47(12):3147-51. PubMed ID: 3581064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor-associated antigens as immunotherapy targets.
    Phillips NC; Major PP; Sikorska H
    Cancer Detect Prev; 1988; 12(1-6):451-9. PubMed ID: 3263200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens.
    Kahan BD; Tanaka T; Pellis NR
    J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study on colon cancer-prone rats of WF-Osaka strain.
    Miyamoto M; Tani Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):1-12. PubMed ID: 2485390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth of transplanted rat tumors following administration of cell-free tumor antigens.
    Tracey RS; Wepsic HT; Alaimo J; Morris HP
    Cancer Res; 1978 May; 38(5):1208-12. PubMed ID: 205357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trial.
    Hollinshead A; Elias EG; Arlen M; Buda B; Mosley M; Scherrer J
    Cancer; 1985 Aug; 56(3):480-9. PubMed ID: 4005810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Immunotherapy of chemically induced rat colon cancer].
    Martin MS; Martin F
    Ann Immunol (Paris); 1977; 128(1-2):129-30. PubMed ID: 322575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines.
    Hanna MG; Peters LC; Hoover HC
    Prog Clin Biol Res; 1989; 310():51-65. PubMed ID: 2672023
    [No Abstract]   [Full Text] [Related]  

  • 55. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
    Shinitzky M; Skornick Y
    Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunotherapy of experimental colonic cancer: immunologic enhancement of grafted tumor].
    Martin MS; Martin F; Lagneau A; Horiot JC; Chomono R
    Biol Gastroenterol (Paris); 1974; 7(4):249-52. PubMed ID: 4464986
    [No Abstract]   [Full Text] [Related]  

  • 57. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer.
    Hollinshead A
    Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunotherapy of postoperative cancer patients with immune RNA-sensitized lymphocytes and tumor antigen].
    Fukushima M; Takashima K; Sato M; Yamauchi M; Tachibana M; Kawaguchi T; Koie H
    Nihon Geka Gakkai Zasshi; 1983 Mar; 84(3):196-202. PubMed ID: 6674792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.
    Steele G; Sjögren HO
    Cancer Res; 1974 Aug; 34(8):1801-7. PubMed ID: 4366501
    [No Abstract]   [Full Text] [Related]  

  • 60. Extraction of immunogenic murine mammary tumor antigens with 1-butanol.
    Gregory SA; Myers WL
    Immunol Invest; 1987 Jun; 16(4):295-312. PubMed ID: 3428947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.